08/12/2025
Rocamed & Delmont imaging: Forging a New Uro-Gyn Era
When gynecology meets urology, innovation happens. We are proud to announce the strategic acquisition of Delmont imaging by Rocamed, a transformative milestone that positions Delmont imaging at the heart of a leading Uro-Gyn MedTech specialist.
This acquisition brings together two highly complementary French MedTech players with strong international presence and shared DNA. It also marks a major step in Delmont imaging’s journey into a fast-growing group that has significantly strengthened its governance and operations over the past year.
Founded in 2011, Rocamed is a global medical device company specializing in endo-urology, developing, manufacturing and distributing a complete product range for urology, with a strong focus on stone management and prostate treatment. Over the years, Rocamed has established itself as a reference in urological technologies through:
• A comprehensive portfolio of innovative, high-end devices and consumables
• A global footprint in 70+ countries
• A large and diversified customer base worldwide
With sustained double-digit growth and recognised clinical credibility, Rocamed brings meaningful scale and complementary technologies to our development roadmap.
This acquisition strengthens the strategy to build a unique, integrated Uro-Gyn platform, giving the Group the critical size, capabilities, and governance required to scale internationally, further reinforcing the Group’s ability to accelerate innovation and global expansion.
